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Case Report
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Lesson
This report provides a rare histological example and the
appropriate management of spontaneous aortic dissection
secondary to giant cell arteritis.
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Introduction
A 69-year-old gentleman presented to the Accident
and Emergency Department at a local district general
hospital with severe sudden-onset chest, back and
abdominal pain. He was assessed and diagnosed,
radiologically, to have acute Stanford type B aortic
dissection beginning at the distal aortic arch at the
level of the left subclavian artery and transferred to
a regional teaching hospital. He received a stent to the
superior mesenteric artery for malperfusion, with
good restoration of mesenteric ﬂow. The following
morning, he was noted on a repeat computed
tomography scan to have the dissection extending
proximally to involve his ascending aorta and aortic
root, thus becoming a Stanford type A dissection
(Figure 1). He was transferred as an emergency to a
tertiary care centre in Edinburgh, in preparation for
emergency surgical repair. Postoperatively, he made
an uneventful recovery. The histopathology report of
the excised dissected aorta specimen had shown fea-
tures consistent with a histological diagnosis of giant
cell arteritis and elastic fragmentation, suggestive of
degenerative vascular disease (Figures 2 and 3).
Contact with Rheumatology was made urgently and
he was commenced on high-dose steroid therapy. He
was transferred back to his local district general hos-
pital for further medical optimisation and
rehabilitation.
Previous to this, he had been ﬁt and well and a
keen golf player. Further questioning revealed that
he had been suﬀering a spell of intractable headaches
from November 2015 to January 2016, before
settling. He also had a spell of severe gum inﬂamma-
tion with loss of teeth preceding that. He did not have
a history of ischaemic heart disease. Operation: emer-
gency repair of Stanford type A aortic dissection with
replacement of aortic valve, aortic root and ascending
aorta: biological Bentall using a 25-mm Carpentier-
Edwards perimount into a 28-mm Gelweave Valsalva
graft.
Discussion
Clinically occult giant cell arteritis is evident in
approximately 50% of patients preceding aortic dis-
section.1,2 In a retrospective cohort study by
Figure 1. CTaorta showing (a) Stanford type B dissection
(left) and (b) superior mesenteric artery stent in situ and
Stanford type A dissection.
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Nuenninghoﬀ et al.,3 nine patients (5%) of those
diagnosed with giant cell arteritis, over 50 years of
age, developed aortic dissection without aneurysm,
with a case mortality of 77%. Liu et al.4
demonstrated that 46% of patients with histopathol-
ogy-conﬁrmed giant cell arteritis presented with
aortic dissection as their ﬁrst presentation, with
85% involving the proximal aorta, resulting in a
two-week mortality rate of 80% mainly due to fatal
pericardial tamponade.4,5
The American College of Rheumatology
classiﬁcation criteria for giant cell arteritis include
(1) age over 50 years, (2) recent-onset localised
headache, (3) tenderness or pulse attenuation on tem-
poral artery palpation, (4) erythrocyte sedimentation
rate above 50mm/h and (5) arterial biopsy showing
necrotising vasculitis.6 The diagnostic gold standard
is histopathological via arterial wall biopsy, with a
positive predictive value of 50–80% based on the clin-
ical disease pattern.7 The estimated median time from
diagnosis of giant cell arteritis to identiﬁcation of
thoracic aortic dissection is 1.1 years.2 Given the
potential morbidity of delayed treatment, investiga-
tion and immediate management should be guided
by high clinical suspicion. Typical laboratory ﬁndings
include normocytic anaemia and reactive thrombocy-
tosis. Hypoalbuminaemia may be evident, and
25–35% of patients will have increased liver trans-
aminases and alkaline phosphatase, with normalisa-
tion on commencing steroid treatment. Erythrocyte
sedimentation rate is often greater than 100mm/h,
although C-reactive protein levels may correlate
better with disease activity.7,8 Early radiological ima-
ging may expedite prompt treatment to prevent long-
term complications.
First-line management includes corticosteroid
therapy. Prognosis is closely related to the time
elapsed before initiation. Guidelines recommend
high-dose prednisolone, 40–60mg, or its equivalent
as ﬁrst-line treatment, although recent evidence sup-
ports similar eﬃcacy with 30–40mg daily.8
Approximately 2–3 months after therapy initiation,
once the disease is adequately controlled, tapering
of steroid therapy is appropriate and maintenance
may continue for years.4 Currently, there are no
evidence-based recommendations to guide steroid
therapy after aortic dissection.
Figure 2. Aortic wall stained with Verhoeff-Van Gieson
stain, showing disruption of the elastic fibres within the
elastic media.
Figure 3. Microscopy from aorta taken intraoperatively: the aortic wall shows a chronic inflammatory cell infiltrate comprising
lymphocytes and scattered admixed multinucleated giant cells.
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Conclusion
This case provides a rare histological example of
spontaneous aortic dissection secondary to occult
and undiagnosed GCA with a good outcome after
surgical intervention. It reinforces the importance of
histological examination of excised aortic tissue from
thoracic aneurysms. Diagnosis and treatment should
be based on high clinical suspicion, and follow-up
imaging is required to detect large-vessel involvement.
Further evidence is needed regarding the surveillance
and treatment of dissections in patients with giant cell
arteritis, as well as steroid therapy after giant cell
arteritis-associated aortic dissection.
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